SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sadaf Aghevlian, Amanda J. Boyle, Raymond M. Reilly, Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons, Advanced Drug Delivery Reviews, 2015,

    CrossRef

  2. 2
    K J Yong, D E Milenic, K E Baidoo, M W Brechbiel, 212Pb-radioimmunotherapy potentiates paclitaxel-induced cell killing efficacy by perturbing the mitotic spindle checkpoint, British Journal of Cancer, 2013, 108, 10, 2013

    CrossRef

  3. 3
    Pasquale De Bonis, Giorgio Lofrese, Carmelo Anile, Angelo Pompucci, Vera Vigo, Annunziato Mangiola, Radioimmunotherapy for high-grade glioma, Immunotherapy, 2013, 5, 6, 647

    CrossRef

  4. 4
    Timo L.M. ten Hagen, Ann L.B. Seynhaeve, Gisela aan de Wiel-Ambagtsheer, Ernst A. de Bruijn, Sandra T. van Tiel, Curzio Ruegg, Michael Meyring, Matthias Grell, Simon L. Goodman, Alexander M.M. Eggermont, The αVβ3/αVβ5 integrin inhibitor cilengitide augments tumor response to melphalan isolated limb perfusion in a sarcoma model, International Journal of Cancer, 2013, 132, 11
  5. 5
    Egesta Lopci, Arturo Chiti, Maria Rita Castellani, Giovanna Pepe, Lidija Antunovic, Stefano Fanti, Emilio Bombardieri, Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies, European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38, S1, 28

    CrossRef

  6. 6
    Kwon Yong, Martin W. Brechbiel, Towards translation of 212Pb as a clinical therapeutic; getting the lead in!, Dalton Transactions, 2011, 40, 23, 6068

    CrossRef

  7. 7
    Scott T. Tagawa, Himisha Beltran, Shankar Vallabhajosula, Stanley J. Goldsmith, Joseph Osborne, Dan Matulich, Kristen Petrillo, Sarojben Parmar, David M. Nanus, Neil H. Bander, Anti–prostate-Specific membrane antigen-based radioimmunotherapy for prostate cancer, Cancer, 2010, 116, S4
  8. You have free access to this content8
    Marcus P. Kelly, Sze Ting Lee, F.-T. Lee, Fiona E. Smyth, Ian D. Davis, Martin W. Brechbiel, Andrew M. Scott, Therapeutic efficacy of 177Lu-CHX-A″-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy, The Prostate, 2009, 69, 1
  9. 9
    C. Andrew Boswell, Martin W. Brechbiel, Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view, Nuclear Medicine and Biology, 2007, 34, 7, 757

    CrossRef

  10. 10
    Atsushi Obata, Shingo Kasamatsu, Jason S. Lewis, Takako Furukawa, Shinji Takamatsu, Jun Toyohara, Tatsuya Asai, Michael J. Welch, Susan G. Adams, Hideo Saji, Yoshiharu Yonekura, Yasuhisa Fujibayashi, Basic characterization of 64Cu-ATSM as a radiotherapy agent, Nuclear Medicine and Biology, 2005, 32, 1, 21

    CrossRef

  11. 11
    Akemi Kataoka, Mayumi Ishida, Shigeru Murakami, Shinji Ohno, Sensitization of chemotherapy by anti-HER, Breast Cancer, 2004, 11, 2, 105

    CrossRef

  12. 12
    Wolfgang A Bethge, Brenda M Sandmaier, Targeted cancer therapy and immunosuppression using radiolabeled monoclonal antibodies, Seminars in Oncology, 2004, 31, 1, 68

    CrossRef

  13. 13
    Andrew P. Morokoff, Ulrike Novak, Targeted therapy for malignant gliomas, Journal of Clinical Neuroscience, 2004, 11, 8, 807

    CrossRef

  14. 14
    Naomi R. Schechter, David J. Yang, Ali Azhdarinia, Sahar Kohanim, Richard Wendt, Chang-Sok Oh, Mickey Hu, Dong-Fang Yu, Jerry Bryant, K. Kian Ang, Kenneth M. Forster, E. Edmund Kim, Donald A. Podoloff, Assessment of epidermal growth factor receptor with 99mTc–ethylenedicysteine–C225 monoclonal antibody, Anti-Cancer Drugs, 2003, 14, 1, 49

    CrossRef